Skip to main content

Table 3 EORTC-C30 and -BN20 domain and single item's scores before and 3 months after VMAT

From: Simultaneous in-field boost for patients with 1 to 4 brain metastasis/es treated with volumetric modulated arc therapy: a prospective study on quality-of-life

QoL Pre-VMAT scoren ± SD Score during VMAT ± SD p value
C30    
Global Health Status 65.4 ± 22.8 60.1 ± 26.6 0.72
Physical functioning 81.4 ± 17.6 63.3 ± 29.8 0.05
Emotional functioning 77.7 ± 21.2 74.4 ± 26.2 0.91
Role functioning 72.6 ± 22.3 45.2 ± 37.8 0.01
BN20 domains/items    
Domains    
Future uncertainty 27.1 ± 20.7 27.4 ± 31.6 0.66
Visual disorder 12.7 ± 21.3 15.1 ± 21.2 0.25
Motor dysfunction 21.4 ± 24.8 22.2 ± 33.5 0.96
Communication deficit 23.0 ± 30.3 27.8 ± 29.5 0.55
Single items    
Headache 33.3 ± 37.0 7.1 ± 14.2 < 0.05
Hair loss 14.3 ± 31.2 23.8 ± 30.5 0.48
Weakness of legs 21.4 ± 24.8 28.6 ± 34.2 0.39
Bladder control 21.4 ± 33.6 11.9 ± 24.8 0.26
  1. Abbreviations: QoL: Quality of life; SD, standard deviation.